Andrew James Watts,Hans Roland Lönn,Helena Nicklasson,Lars-Erik Briggner,Marie-Lyne Alcaraz,Per Tomas Klingstedt,Robert Anthony Nixon,Robert Zuban
申请号：
BRPI1008396
公开号：
BRPI1008396A2
申请日:
2010.02.18
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
6-Methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form.
